FILING ANALYSIS · THURSDAY, NOVEMBER 12
IMMUCELL CORP /DE/ ICCC — 8-K: Results of Operations and Financial Condition
positive
ImmuCell reports strong Q3 results with 46% revenue growth and a net income of $953,000, also terminating its At-The-Market offering due to a strong cash position.
How we read impact: we grade every directional call in the open. Impact labels are AI estimates — not investment advice. See the full disclaimer.
Get filings like this every market day
The US SEC filings, UK RNS, EU notices, and Polymarket odds that matter — scored by AI, in one email.
Subscribe free →